Abstract:Objective To investigate the serum DNA methylation transferase 1 (DNMT1) level and its clinical significance in patients with chronic hepatitis B. Methods One hundred and twenty patients with chronic hepatitis B admitted to Hangzhou Xixi Hospital from January 2019 to December 2019 were selected as the hepatitis B group, and 120 healthy people who were examined during the same period were used as the control group. The levels of aspartate aminotransferase (AST), alanine aminotransferase (ALT), total bilirubin (TBIL), log hepatitis B virus (Log HBV), tumor necrosis factor-α (TNF-α) and DNMT1 were measured. Results The serum AST, ALT, TBIL, TNF-α and DNMT1 levels in the hepatitis B group were higher than those in the control group (P < 0.05). The serum DNMT1 level of patients with hepatitis B was positively correlated with AST (r = 0.524), ALT (r = 0.573), TBIL (r = 0.559) and TNF-α (r = 0.519) (P < 0.05). The AST, ALT, TBIL, TNF-α, Log HBV and DNMT1 levels in HBeAg positive group were higher than those in HBeAg negative group (P < 0.05). The serum DNMT1 level in HBeAgpositive patients was positively correlated with AST (r = 0.602), ALT (r = 0.615), TBIL (r = 0.584), TNF-α (r = 0.565) and Log HBV (r = 0.631) (P < 0.05). The serum DNMT1 level in the severe inflammation group was higher than that in the mild inflammation group (P < 0.05). The serum DNMT1 level in severe fibrosis group was higher than that in mild fibrosis group (P < 0.05). Conclusions Chronic hepatitis B patients have elevated serum DNMT1 levels, which are closely related to liver function, liver inflammation and fibrosis.